title: [Elevation of compliance and motivation to antihypertensive therapy in patients with arterial hypertension by way of educational programs and rational use of angiotensin converting enzyme perindopril. Results of the PRISMA study].
authors.forename: Zh D
authors.initials: ZhD
authors.lastname: Kobalava
authors.forename: S V
authors.initials: SV
authors.lastname: Villeval'de
authors.forename: Kh V
authors.initials: KhV
authors.lastname: Isikova
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D058070:Asymptomatic Diseases / Q000453:epidemiology; D001794:Blood Pressure / Q000187:drug effects*; D018660:Blood Pressure Monitoring, Ambulatory; D002983:Clinical Competence / Q000592:standards; D003695:Delivery of Health Care / Q000592:standards; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D008019:Life Style; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology / Q000706:statistics & numerical data; D010353:Patient Education as Topic / Q000458:organization & administration*; D020913:Perindopril / Q000008:administration & dosage / Q000009:adverse effects; D011314:Preventive Health Services / Q000458:organization & administration* / Q000706:statistics & numerical data; D015397:Program Evaluation; D012307:Risk Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril